Abstract
The historically fragmented biomedical data ecosystem has moved towards harmonization under the findable, accessible, interoperable, and reusable (FAIR) data principles, creating more opportunities for cloud-based research. This shift is especially opportune for scientists across diverse domains interested in implementing creative, nonstandard computational analytic pipelines on large and varied datasets. However, executing custom cloud analyses may present difficulties, particularly for investigators lacking advanced computational expertise. Here, we present an accessible, streamlined approach for the cloud compute platform CAVATICA that offers a solution. We outline how we developed a custom workflow in the cloud, for analyzing whole genome sequences of case-parent trios to detect sex-specific genetic effects on orofacial cleft risk, which required several programming languages and custom software packages. The approach involves just three components: Docker to containerize software environments, tool creation for each analysis step, and a visual workflow editor to weave the tools into a Common Workflow Language (CWL) pipeline. Our approach should be accessible to any investigator with basic computational skills, is readily extended to implement any scalable high-throughput biomedical data analysis in the cloud, and is applicable to other commonly used compute platforms such as BioData Catalyst. We believe our approach empowers versatile data reuse and promotes accelerated biomedical discovery in a time of substantial FAIR data.
Competing Interest Statement
Eric Tobin is an employee of Velsera, the developer of the Seven Bridges platform.
Funding Statement
S.B., K.K., M.L.M and I.R. were supported by NIDCR R01-DE031855. This work was also supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. Data collection was supported by R01-DE016148, and sequencing by X01-HD100701.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for this study was given by the following Ethics Committees: University of the Philippines, Manila, Research Ethics Board (FWA00018728); the University of Iowa Institutional Review Board (FWA00043007, IRB approval ID# 200812719); the University of Pittsburgh Institutional Review Board (FWA00006790, IRB approval ID# STUDY19080127). Informed consent was obtained for all participants using a certified translation into Tagalog of the English consent form approved by the study coordinating center at the University of Pittsburgh.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The trio data are available in the Genomics of Orofacial Clefts in the Philippines workspace on CAVATCA and on dbGaP under study accession number phs002595.v1.p1
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002595.v1.p1
